MIT's CSAIL institute is located in the Stata Center. Credit: Google Maps
ReMix, a new technology in the works at MIT's Computer Science and Artificial Intelligence Laboratory, seeks to make progress toward a new paradigm of treatment – one that's less reliant on endoscopy and surgery, but instead relies on sensors and what scientists call an "in-body GPS" to help make diagnoses and guide drug administration.
The goal, researchers said, is a new approach to patient...
As precision medicine and its related technologies take off in healthcare with rocket-like speed, many players in the space are advocating for a balance between innovation and regulation. Without policies in place, there are major mistakes that hospitals, researchers, clinicians, and policymakers will need to avoid to ensure that the healthcare system remains available to all, according to...
Genomic sequencing has come a long way in a short time, and its potential to drive even faster innovations in precision medicine is enormous.
To capitalize on that opportunity, however, health systems need data – lots of it, from all sorts of people. Kaiser Permanente has been building a biobank with genomic data and other health information from hundreds of thousands of patients from across its...
Boston-based Antidote Technologies expects it will soon be able to accelerate the development of capabilities for its trial matching platform – including precision medicine and EHR matching. That’s because the company has just entered into an agreement for an $11 million funding round led by Merck Global Health Innovation Fund, and joined by existing investors Smedvig Capital and Octopus Ventures...
Hearing the word “precision” in healthcare typically conjures ideas of cutting edge technologies and treatments like targeted genetic therapy. But it has another meaning in primary care: leveraging data from a variety of sources to deliver personalized, preventive care.
“It’s a way to bring the big data – whether that is on the population level, from digital health devices like wearables, or...
Just like online streaming giant Netflix uses behavior data to recommend movies and shows to customers, medicine is on the cusp of becoming that personalized in its approach.
“We are not applying that same kind of data understanding in healthcare today and we really should be, and will be in the future,” said India Hook-Barnard, director of research strategy and associate director of precision...
The days of claiming artificial intelligence as a feature that set one startup or company apart from the others are over. These days, one would be hard-pressed to find any technology company attracting venture funding or partnerships that doesn’t posit to use some form of machine learning. But for companies trying to innovate in healthcare using artificial intelligence, the stakes are...
The promise of precision medicine is starting to be realized. The combination of patient medical records and genomic data is proving to be a potent source of data for clinicians as they apply analytical tools in the search for better treatments.
But one factor holds back many new initiatives. The data available for analysis is limited to the records of patients who are participating in any given...
The importance of genomic and patient-generated data will increase dramatically in the next five years as healthcare managers gain control of big data to develop precision medicine.
Forty percent of respondents to a new survey, in fact, said genomic data will become one of the most useful data sources in five years, up from just 17 percent today. And 40 percent said patient-generated data will be...
Global pharmaceutical company Teva has joined forces with IBM in a three-year research collaboration that integrates with the Watson Health Cloud. The project builds on an existing alliance between the two companies and will focus on two key areas in healthcare: developing a systematic approach to discovering new uses for existing drugs and improving chronic disease management.
The joint work in...
